Adalimumab Injection
for subcutaneous use Initial U.S. Approval: 2002

adalimumab is a tumor necrosis factor (TNF) blocker indicated for treatment of: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis or Pediatric Uveitis.

Facts about Adalimumab Injection

Approval Date:2002
Proprietary Name: On Request
Active Ingredient(s): Adalimumab Injection
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “Adalimumab Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

CIMZIA (certolizumab pegol) injection

CIMZIA is a tumor necrosis factor (TNF) blocker indicated for (1) Reducing signs and symptoms of Crohn’s disease and maintaining clinical (2) response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy (3) Treatment of adults with moderately to severely active rheumatoid arthritis (4) Treatment of adult patients with active psoriatic arthritis. (5) Treatment of adults with active ankylosing spondylitis.

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import CIMZIA (certolizumab pegol) injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

ILARIS (canakinumab) Injection for Subcutaneous use

Canakinumab is Generic Name for the trade name drug Ilaris. Ilaris is manufactured by Novartis. Ilaris is approved by FDA. Date of approval: June 2009

Name: ILARIS
Generic Name: Canakinumab
Strength: single-use vial.
Manufactured: Novartis pharmaceutical corporation

ILARIS is an interleukin-1β blocker indicated for the treatment of: 1. Cryopyrin-Associated Periodic Syndromes (CAPS), Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS). 2. Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS). 3. Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD). 4. Familial Mediterranean Fever (FMF). Active Systemic Juvenile Idiopathic Arthritis (SJIA).

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import ILARIS (canakinumab) Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.